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Abstract
Background: Developments in DNA resequencing microarrays include mitochondrial DNA (mtDNA) sequencing
and mutation detection. Failure by the microarray to identify a base, compared to the reference sequence, is
designated an ‘N-call.’ This study re-examined the N-call distribution of mtDNA samples sequenced by the
Affymetrix MitoChip v.2.0, based on the hypothesis that N-calls may represent insertions or deletions (indels) in
mtDNA.
Findings: We analysed 16 patient mtDNA samples using MitoChip. N-calls by the proprietary GSEQ software were
significantly reduced when either of the freeware on-line algorithms ResqMi or sPROFILER was utilized. With
sPROFILER, this decrease in N-calls had no effect on the homoplasmic or heteroplasmic mutation levels compared
to GSEQ software, but ResqMi produced a significant change in mutation load, as well as producing longer N-cell
stretches. For these reasons, further analysis using ResqMi was not attempted. Conventional DNA sequencing of
the longer N-calls stretches from sPROFILER revealed 7 insertions and 12 point mutations. Moreover, analysis of
single-base N-calls of one mtDNA sample found 3 other point mutations.
Conclusions: Our study is the first to analyse N-calls produced from GSEQ software for the MitoChipv2.0. By
narrowing the focus to longer stretches of N-calls revealed by sPROFILER, conventional sequencing was able to
identify unique insertions and point mutations. Shorter N-calls also harboured point mutations, but the absence of
deletions among N-calls suggests that probe confirmation affects binding and thus N-calling. This study supports
the contention that the GSEQ is more capable of assigning bases when used in conjunction with sPROFILER.
Background
Until recently, studies examining sequence variations
within human mitochondrial DNA (mtDNA) have been
based on restriction fragment length polymorphisms
(RFLP) analysis. With the development of the high-
throughput sequencing of PCR products, which is highly
sensitive, specific and relatively low cost, it has become
more common in the medical and forensic fields to
sequence the whole mitochondrial genome [1]. As a result,
more rapid sequencing using microarrays-based resequen-
cing is being used increasingly in clinical and research
laboratories for identifying mutations throughout the
entire mtDNA genome. Resequencing microarrays are a
promising technology for diagnostic mitochondrial disor-
ders and related diseases based on changes at the genetics
level [2-5]. However, validation of output data particularly
for mtDNA, i.e., the accuracy of base identification (or
call) for homoplasmic and heteroplasmic mutations, as
well as detection insertions or deletions (indels) from
these microarrays-based resequencing chips has been a
major issue [2,6,7].
The Affymetrix second-generation human mitochon-
drial resequencing microarray (MitoChip v2.0) was
released in 2006. In addition to sequencing the entire
mitochondrial genome including the noncoding region
(D-loop), it also contains redundant tiling of sequences
for 500 of the most common haplotypes including single-
nucleotide changes. Each mitochondrial gene of interest
is represented by sets of oligonucleotide probes with a
matching sequence as reported in MITOMAP: A Human
Mitochondrial Genome Database, http://www.mitomap.
org [3,4,6]. The MitoChip v2.0 software (GSEQ) assigns a
base call at any given position by using the International
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codes), and then compares the base call to the Cambridge
R e f e r e n c eS e q u e n c e( r C R S ) .Ab a s ec a l lw i l lb ea s s i g n e d
either as a wildtype (WT), homoplasmic sequence variant
(the presence of a point mutation within all of the
mtDNA copies), heteroplasmic sequence variant (the pre-
sence of a mixture of more than one type of mtDNA
copies some are wildtype and some with point mutation
or both copies are point mutations, i.e., both differing
from rCRS), or N-call [8].
Failure of the MitoChip v2.0 software to assign a base to
any position (N-call) can be for several reasons. In three
independent studies, it was concluded that despite
improvements in call rate and accuracy achieved by
adjusting the GSEQ software parameters, the call rates
remain less accurate and less sensitive than conventional
dye-terminator sequencing. This failure was attributed to
poor hybridization at regions with ≥4 sequential C bases
and poor probe performance, [9] as well as variability of
the individual target sequence [6,10]. The GSEQ software
may also return N-calls and even false-positives when
poor hybridization resulting from deletion are present in
the sample mtDNA [9]. Balanced against these deficits, the
MitoChip still provides a high-throughput tool that is fast,
easily automated, and cost-effective for targeting regions
of mtDNA sequence variation, with reasonable accuracy
[8].
We surveyed the literature for publications relating to
re-analysing data generated by resequencing microarrays
and specifically for insights into N-call analysis derived
from resequencing data. One study used a novel DNA
array (Birmingham ReseqUencing Microarray version 1-
BRUM1) designed to analyse 92 nuclear DNA genes
(involved in metabolic pathways) using specific probes to
detect point mutations or known indels, in addition to
sequencing. While most deletions (7/10) were not
detected, the three samples with homozygous deletions
were detected as ‘stretches’ o fN - c a l l s .F u r t h e r m o r e ,n o
obvious reduction in signal intensity was observed at the
deletion sites [7]. In a second study, a new software algo-
rithm was developed, ResqMi, that used intensity compari-
sons to enhance the call rates of resequencing microarray
data [11]. Three different resequencing microarrays were
analysed using ResqMi: ‘CFTR’ (targeting the human
CFTR gene), ‘SARS’ (for the Corona virus causing Severe
Acute Respiratory Syndrome), and ‘Mito’ (which became
the Affymetrix MitoChip v.1.0). This software succeeded
in resolving up to 10% of the N-calls on all three array
types using GSEQ as the primary software. In a third
study, another software algorithm, sPROFILER, succeeded
in resolving more than 80% of N-calls from GSEQ soft-
ware and allowed 99.6% of their resequencing array to be
assigned a base call. An interesting observation in this
study was the detection of a continuous stretch of 13 N-
calls and a variant call that was attributable to a series of
deleted bases in the TMPRSS3 gene [2].
For a project we were conducting to examine mutations
in mtDNA, we were particularly interested in the detection
of indels. As the MitoChip’s GSEQ software has no provi-
sion for detecting these, we compared the analysis of our
mtDNA N-call distribution in the rCRS section using
GSEQ, ResqMi and sPROFILER software, based on the
hypothesis that N-calls may include indels in mtDNA.
Furthermore, it has been reported that depending upon
the sequence context, point mutations generally produce
the weakest inhibition of probe annealing (least likely to
produce an N-call), followed by deletions then insertions
[12]. Thus, when searching for indels we expected the
highest success would come from examining longer N-call
stretches in a sample.
Materials and methods
Patient samples
Total DNA was extracted from 16 patient samples, com-
prising 8 peripheral blood/bone marrow samples and 8
fibroblasts cultures. Blood or bone marrow samples were
from 7 patients with myelodyplastic syndrome (MDS) and
one patient with chronic lymphoblastic leukemia (CLL),
obtained from the Australasian Leukaemia and Lym-
phoma Group Tissue Bank, Princess Alexandra Hospital,
B r i s b a n e ,A u s t r a l i a ,a n dt h eH e m a t o l o g yC l i n i ca tM a t e r
Adult Hospital, Brisbane. Low passage fibroblast cultures
from 8 pediatric patients with metabolic disorders indica-
tive of mitochondrial dysfunction were obtained from the
Department of Pathology (Cytogenetics), Mater Adult
Hospital, Brisbane. This study was approved by the institu-
tional Human Ethics Review Committees of The Univer-
sity of Queensland and the Mater and Princess Alexandra
Hospitals, Brisbane, Australia.
Automated Batch Analysis of Microarray Data
Data analysis of microarrays was carried out using GSEQ
software. The Affymetrix MitoChip v.2.0 is tiled with 25-
mer DNA probes divided into two sections, the first repre-
senting the Cambridge Reference Sequence (rCRS)
NC_012920 of mtDNA, while the second section com-
prises sequences representing 500 of the most common
haplotypes recorded in the MitoMap public database
http://www.mitomap.org/. These include known mtDNA
single nucleotide polymorphisms (SNPs) as well as known
pathological mutations or indels. Each base position of
mtDNA is represented on the MitoChip by several, tens
or hundreds of tiles (i.e., redundant tiling to probe unique
or new mutations are repeated many times on the array)
[4,8].
The Affymetrix GSEQ algorithm parameter settings
recommended to achieve optimal performance were
used to analyze the mitochondrial sequences, with
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detection of heteroplasmy. A Quality Score Threshold
(QST) of 3 provided the highest performance in terms
of overall base calling accuracy and call rates by the
software [10]. The GSEQ MitoChip v2.0 microarray
software assigns homoplasmic mutations (IUPAC codes
A, C, G or T); heteroplasmic mutations (IUPAC codes
R, Y, K, M, S, or W), or an N-Call where a base position
cannot be assigned by the software.
All microarray (CEL files and CHP files), GSEQ and
sPROFILER sequencing data outputs, and all sample infor-
mation were uploaded to the series records (GSE29550) of
Gene Expression Omnibus (GEO).
sPROFILER and ResqMi software for N call analyses
Data from GSEQ base calls was further analysed using
sPROFILER (strand-specific PRObe cell intensity compari-
son for FILtERing) [2] and ResqMi (REF). sPROFILER is
free software designed by Kothiyal et al as a novel algo-
rithm developed to improve GSEQ array call rates. It uses
MATLAB, a numerical computing and programming lan-
guage, and is based on intensity signature. When a base
cannot be called because of poor hybridization on one of
the strands, a threshold is determined by using the next
highest intensity ratio on either strand to determine the
base call. sPROFILER was not designed to query base calls
conforming to the reference sequence (rCRS), as GSEQ is
conservative in assigning a base call. Code and detailed
description of the sPROFILER algorithm are available at
http://www.biomedcentral.com/content/supplementary/
1472-6750-10-10-S2.TXT
ResqMi is a base calling algorithm using intensity com-
parisons and region-wise conformance assessment, to
enhance the call rates as well as analysing N-calls pro-
duced by microarray gene chips [11]. The algorithm
applied two quality measures for filtering any base calls,
starting by measuring the conformance (i.e., the fraction of
bases equal to the reference in a sliding window on the
rCRS), followed by the next highest intensity ratio for each
base, to assess signal quality. ResqMi is open source soft-
ware, available at http://www-ps.informatik.uni-tuebingen.
de/resqmi.
Conventional sequencing of N call stretches
To analyse the nature of N-calls from the sPROFILER
output data, the longest N-cell stretch from each of the
16 mtDNA samples was conventionally sequenced, with
the 2 following exceptions. For sample mtDNA8 had the
3 longest N-call stretches sequenced, while mtDNA from
one fibroblast cell line sample (mtDNA7), which was
homozygous for the 94C > A sequence variant of the
nucleotidase gene ITPA, was conventionally sequenced
across the whole mitochondrial genome, because of other
research interests in this gene [13].
For sample mtDNA7, the entire sequence of the mito-
chondrial genome was amplified, using 36 pairs of M13-
tagged oligodeoxynucleotide primers as described pre-
viously by Taylor et al., 2003 [14]. For the remaining
mtDNA samples, the longest stretch of N-calls of each
sample was amplified using the appropriate primer for
each N-cell stretch, noting that the primers usually
extended beyond the ends of the specified stretches.
Amplified PCR products were purified (ExoSapIT, GE
Healthcare, Buckinghamshire, UK), then sequenced using
BigDye
® Terminator v3.1 chemistries (Applied Biosystems,
UK) on an ABI3130xl Genetic Analyser and directly
compared to the revised Cambridge reference sequence
(GenBank Accession number NC_012920) using SeqScape
software (v2.1.1, Applied Biosystems, UK). The conven-
tional sequencing results were then compared with Mito-
Chip results analysed by GSEQ, ResqMi and sPROFILER.
Results
Table 1 shows the mean of GSEQ N-calls across the 16
samples; both in the rCRS section of the MitoChip and
across the total GeneChip (include the 500 common
haplotypes). It can be seen that when samples were
further analysed using ResqMi or sPROFILER, there was
a striking reduction in the N-call numbers, averaging
35% and 61% decreases respectively for the rCRS sec-
tion, and 27% and 21% for the haplotypes section, across
the 16 samples. These decreases were significant for all
samples (P < 0.0003 to < 0.0005), calculated using the
Wilcoxon signed rank test.
Figure 1 shows re-analyses of the N-call stretches pro-
duced by GSEQ using sPROFILER (See: Additional file 1,
Table S1) or ResqMi (See: Additional file 1, Table S2),
where approx. 2% of the remaining N-call stretches were
≥5 bases for both re-analyses. Interestingly, the two long-
est stretches from the GESEQ analysis (e.g. 20 and 18
bases) remained following ResqMi or sPROFILER re-ana-
lyses. Visual inspection of Figure 1 suggested that each
sample may have hundreds of single base N-calls, but the
incidence of N-calls decreased suddenly for N-call
stretches of approximately 4 or more bases. We re-ana-
lysed the standard deviation of N-call stretches using
‘Control Chart’ (or Shewhart Chart), a statistical calcula-
tion which puts natural process limits on sets of data (See:
Additional file 1, Figure S1). Control Chart output found
that N-call stretches ≥ 4 bases long were within a limit of
3 standard errors. This indicated N-call stretches < 4 con-
tained high variable data which were less likely to mask
genuine underlying biological changes from the reference
sequence, i.e. deletions and insertions (indels).
However, reanalysis using sPROFILER appeared to be
more effective, as it produced fewer and shorter N-call
stretches compared to ResqMi (not shown). Moreover,
it was also noticed that, in contrast to GSEQ and
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the homoplasmic and heteroplasmic mutations) com-
pared to the rCRS greatly increased using the ResqMi
software (See: Additional file 1, Table S3). This sug-
gested using the ResqMi may result in base miscalling,
particularly increasing heteroplasmic calls. To confirm
the accuracy of the new base calls would have required
complete conventional sequencing of all samples. For
sample mtDNA7, comparison of the ResqMi re-analysis
of the MitoChip sequence with complete conventional
sequencing showed that all heteroplasmy calls produced
by ResqMi in fact matched the rCRS as called by con-
ventional sequencing. We did not use this software for
further analyses in this study. Comparison of conven-
tional sequencing with the MitoChip rCRS is discussed
below.
Table 2 shows that N-call stretch lengths ≥ 4 decreased
after re-analysing GSEQ with sPROFILER. Based on the
report that indels may impact on microarray probe
annealing, [12] the longest N-call stretch from each sam-
ple was sequenced conventionally, with two exceptions
(it was not possible to sequence all N-call stretches due
to financial constraints). For sample mtDNA8, the 3
longest N-call stretches (10, 18 and 20 bases) were
sequenced. For sample mtDNA7, complete sequencing
was performed because this was derived from a fibroblast
cell line homozygous for the 94C > A sequence variant of
the nucleotidase gene ITPA (see Methods).
In 6 of the N-call stretches sequenced conventionally,
we found 7 insertions (i.e. one N-call stretch had 2 inser-
tions). Insertion type m.309insC accounted for 6 of the 7
insertions found within the N-call stretches, while
mtDNA9 also had insertion type m.315insC located one
base outside its N-call stretch. Conventional sequencing
revealed 12 point mutations within the N-call stretches.
No deletions were found by conventional sequencing of
the N-call stretches. Of 3 N-call stretches that showed no
sequences differences compared with the rCRS sequence
reference on the MitoChip, 2 were found to be CG-rich.
For the sample mtDNA7, which was completely
sequenced (Table 3), one deletion (m.3107delC) was called
by MitoChip and confirmed by conventional sequencing:
this deletion was acknowledged by Affymetrix as being
omitted from the resequencing array at the time of
GeneChip design due to an error in the original human
mtDNA sequencing [15]-this error has been retained in
the rCRS [16]. One deletion found by conventional
sequencing, m.15944delT, was called as a ‘heteroplasmic
substitution’ by MitoChip, and 2 other deletions
(m.523_524delAC, m.16193delC) were assigned as normal
bases by MitoChip. On the other hand, MitoChip did not
call any insertions in any samples, but conventional
sequencing of mtDNA7 revealed 2 insertions (m.315insC,
m.16193insC) (Table 3).
Moreover, for the 145 N-call bases remaining after
sPROFILER analysis for mtDNA7 (Additional file 1, Table
S1), which ranged from a single N-call base to four N-call
bases length, conventional sequencing revealed that 4 of
these N-call bases to be point mutations (Table 3). One of
these point mutations was found among the N-call
stretches of 4 bases and the other 3 point mutations were
found among single N-calls. The remaining 141 N-calls
matched the rCRS. These results correlated with our sta-
tistical calculation using “Control Chart” (Additional file 1,
Figure S1), which found that N-call stretches < 4 were
high variable data: for this reason the shorter N-call
stretches in the other samples were excluded from con-
ventional sequencing but these may have contained point
mutations or indels.
For mtDNA7, a total of 35 homoplasmic and heteroplas-
mic mutations were identified using MitoChip, with 30 of
these mutations being confirmed by conventional sequen-
cing: 2 new homoplasmic mutations were not detected by
Mitomap, while 5 heteroplasmic mutations (m.1814A > G,
m.11466T > G, m.12307A > G, m.12309A > G, m.13037C
> A) detected by MitoChip were not confirmed by conven-
tional sequencing. Two new homoplasmic substitutions
assigned by MitoChip (m.5264C > T and m.15977C > T)
were not reported on Mitomap but were confirmed by
conventional sequencing. Four single base N-calls assigned
by MitoChip were confirmed by conventional sequencing
as point mutations, three of them were previously reported
by Mitomap (m.146T > C, m.16189T > C, m.16343A > G)
and one was a new mutation (m.464A > C).
Discussion
This project aimed to re-analyse N-call stretches
assigned by GSEQ, the Affymetrix MitoChip v2.0
Table 1 N-call analysis of mtDNA sequences using MitoChip v2.0 with Affymetrix GSEQ, sPROFILER, and ResqMi
software
Software Means of N-Calls in rCRS (n = 16) N-calls decrease % P value Total N-Calls N-calls decrease % P value
GSEQ 623 7212
ResqMi 407 35 p < 0.0005 5284 27 p < 0.0003
sPROFILER 239 61 p < 0.0003 5698 21 p < 0.0003
The results are shown as average of N-Call numbers and % decreases. P value calculated using the Wilcoxon signed rank test comparing the percentage dropi n
N-call using sPROFILER software and ResqMi software against Affymetrix GSEQ software. Total N-calls refer here to both MitoChip sections (rCRS and haplotypes).
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ples. A significant reduction in N-calls has been pre-
v i o u s l yr e p o r t e db yt h eu s eo fs P R O F I L E Ro rR e s q M i
software, which both act essentially by choosing the
ratio of the highest to the next highest signal intensity
on either strand, to improve base calling [2]. However,
the accuracy of either sPROFILER or ReseqMi re-ana-
lyses of GSEQ N-calls has not been demonstrated
Figure 1 The incidence of N-call stretches following mtDNA sequencing using MitoChip with GSEQ vs. sPROFILER and ResqMi
software.
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Sample Name N-Call stretch lengths (bp) Mutation found by conventional sequencing
*GSEQ *sPROFILER
mtDNA1 5, 6, 9, 13 4, 5 1 point mutation (in 5 base stretch)
mtDNA2 5, 6, 12 4, 5, 6 1 point mutation (in 6 base stretch)
mtDNA3 5, 6, 7, 11 4, 10 1 point mutation, 1 insertion (in 10 base stretch)
mtDNA4 5, 6, 11 4, 5 1 insertion (in 5 base stretch)
mtDNA5 5, 13 4, 5 1 insertion (in 5 base stretch)
mtDNA6 5, 7, 11 4, 5, 11 1 point mutation, 1 insertion (in 11 base stretch)
mtDNA7 5, 10 4 Entire mtDNA sequenced: 1 point mutation
(in 4 N-call stretch)
mtDNA8 5, 6, 8, 9, 10, 11, 14, 18, 20 4, 5, 6, 8, 10,
18, 20
1 point mutation (in 20 base stretch)
2 point mutations (in 18 base stretch)
1 point mutation (in 10 base stretch)
mtDNA9 5, 6, 9, 11, 12 4, 5, 8 2 insertions (in 8 base stretch)
mtDNA10 5, 7, 8, 9, 10 4, 5, 7, 9 1 point mutation (in 9 base stretch)
mtDNA11 5, 6, 8, 9, 12 4, 5, 8 1 point mutation (in 8 base stretch)
mtDNA12 5, 9, 10 4, 9 1 insertion (in 9 base stretch)
mtDNA13 5, 7, 8, 9, 10 4, 5, 9 1 point mutation (in 9 base stretch)
mtDNA14 5, 8, 10 4, 5 No point mutation or indel (in 5 base stretch)
mtDNA15 5, 6, 7, 11 4, 5 No point mutation or indel (in 5 base stretch)
mtDNA16 5, 7, 8, 10, 11 4, 6 No point mutation or indel (in 6 base stretch)
*Only stretches ≥ 4 bases identified in GSEQ are listed. For each sample only the longest N-call stretch was sequenced conventionally (except mtDNA7 and
mtDNA8). Shorter N-call stretches occurred multiple times-as seen in Figure 1.
Table 3 mtDNA homoplasmic and heteroplasmic mutations identified in fibroblast sample 7 (mtDNA7)
mtDNA Gene Location Nucleotide Position Ref MitoChip call Nucleotide change Comment
mtDNA7 MitoChip GSEQ Conventional sequencing
D-loop 146 T N T > N T > C N = point mutation (1)
D-loop 315 C C C insC Insertion (1)
D-loop 464 A N A > N A > C N = New point mutation (1)
D-loop 523-524 AC AC AC delAC Deletion (1)
16S rRNA 1814 A R A > G - Heteroplasmic mutation (2)
16S rRNA 3107 C - delC delC Deletion
MTND2 5264 C T C > T C > T New
MTND4 11466 T K T > G - Heteroplasmic mutation (2)
MTTL2 12307 A R A > G - Heteroplasmic mutation (2)
MTTL2 12309 A R A > G - Heteroplasmic mutation (2)
MTND5 13037 C M C > A - Heteroplasmic mutation (2)
MTTT 15944 T Y T > C delT Deletion (3)
MTTP 15977 C T C > T C > T New
D-loop 16189 T N T > N T > C N = point mutation (1)
D-loop 16192 C C C insC Insertion (1)
D-loop 16193 C C C delC Deletion (1)
D-loop 16343 A N A > N A > G N = point mutation (1)
Homozygous for the ITPA 94C > A I sequence variant (ITPA
-/
-), using MitoChip v2.0 vs. conventional sequencing (dye-terminator sequencing). Abbreviations =
mitochondrial genes according to international notation (see www.mitomap.com). In IUPAC base codes r = A or G, k = G or T, m = A or C, y = C or T, and n = A,
C, G or T. The deletion 3107C was omitted from the resequencing array. (1) not assigned by MitoChip; (2) not assigned by conventional sequencing; (3) assigned
by MitoChip as point mutation not as deletion; “-” not detected by conventional sequencing.
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tion in N-calls using both types of software, but we
found that ReseqMi produced a larger number of N-call
stretches compared to sPROFILER, although the longest
N-call stretches (i.e. 18 and 20 bases) of one sample
(mtDNA 8) remained following both ResqMi and sPRO-
FILER analyses. Importantly, although sPROFILER ana-
lysis produced a significant decrease in N-calls, in both
the rCRS and haplotypes sections of the MitoChip, this
did not affect the homoplasmic or heteroplasmic muta-
tion rates compared to Affymetrix GSEQ software,
whereas ResqMi analysis significantly increased the
mutation rates.
The significant decrease in the MitoChip N-calls using
sPROFILER allowed us to narrow down the areas to
search for possible point mutations or indels. We then
used conventional sequencing of the longer N-call
stretches produced by sPROFILER, [2] as well as comple-
tely sequencing one sample (mtDNA7). The conventional
sequencing found 19 mutations overall, comprising 7
insertions and 12 point mutations. Interestingly, conven-
tional sequencing found no deletions among the N-call
stretches examined, but did find insertions.
The failure of the Mitochip to detect deletions (or the
software to assign them as N-calls) presumably arises from
peculiarities in the conformation of the array probes when
binding mtDNA. This corresponds well with a previous
microarray study, which reported that insertions had the
highest negative impact on probe annealing [12]. On the
other hand, both of the longest N-call stretches (18 and 20
bases) contained point mutations (multiple, in the case the
18 base stretch) rather than insertions. Complete conven-
tional sequencing of the sample mtDNA7 showed that 3
out of 145 single-base N-calls in the sample comprised
point mutations, of a total of 17 sequence variants found
in this sample (Table 3). This one example of complete
sequencing thus indicated that shorter N-calls may also
hide sequence variants.
With the significant increases of throughput applications
for large targeted sequencing or whole mitochondrial gen-
ome resequencing the need for new approaches towards
data analysis and variant identification, combined with
higher sequencing accuracy, will become paramount for
both accuracy and to minimise sequencing costs. This is
particularly important for variation in mitochondrial DNA
from different tissues of the same individual, because of
the presence of sequence variants among the large num-
bers of mtDNA copies within a tissue or even in a single
cell [17]. New techniques such as digital sequencing [17]
or ‘next generation sequencing’ [18] may eventually pro-
vide more comprehensive sequencing but their use for
screening will depend upon low cost and ease/speed of
use.
Conclusions
This small study of mtDNA using MitoChip demon-
strated that N-calls stretches can mask important
sequence information. Nonetheless, our study showed
that using MitoChip and GSEQ software coupled with
sPROFILER can provide economical sequence screening
of mtDNA, but with limitations, particularly for calling
indels. Insertions were assigned as N-calls, but one
aspect of the array that still needs further refinement is
the inability to detect deletions [6,9,10]. Our study sug-
gested that gains in economy may be achievable by
focusing conventional sequencing efforts on longer
stretches of N-calls. These stretches were better identi-
fied using sPROFILER than ResqMi software, improving
the base calling and reducing N-calls to those that fre-
quently represented an undefined change (i.e. a point
mutation or insertion) rather than failures of Affymetrix
GSEQ software to assign a call [2].
Additional material
Additional file 1: N-call analyses and homoplasmy/heteroplasmy in
16 mtDNA samples. Comprises: Table S1: N-call analysis of mtDNA
sequences using MitoChip v2.0 with Affymetrix GSEQ and sPROFILER
software. Table S2: N-call analysis of mtDNA sequences using MitoChip
v2.0 with Affymetrix GSEQ and ResqMi software. Table S3: Total sequence
variants (homoplasmic and heteroplasmic) found in mtDNA sequences
compared to rCRS using MitoChip v2.0. Figure S1: Control Chart
calculation based on the standard deviation of the N-call stretches.
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